<Record>
<Term>Recombinant Vaccinia-Prostate Specific Antigen</Term>
<SemanticType>Pharmacologic Substance</SemanticType>
<ParentTerm>Vaccinia Vaccine</ParentTerm>
<ClassificationPath>Chemicals_and_Drugs_Kind/Drug, Food, Chemical or Biomedical Material/Pharmacologic Substance/Biological Response Modifier/Vaccine/Recombinant Viral Vaccine/Vaccinia Vaccine/Recombinant Vaccinia-Prostate Specific Antigen</ClassificationPath>
<BroaderTerm>Chemicals_and_Drugs_Kind</BroaderTerm>
<BroaderTerm>Pharmacologic Substance</BroaderTerm>
<BroaderTerm>Vaccinia Vaccine</BroaderTerm>
<BroaderTerm>Recombinant Vaccinia-Prostate Specific Antigen</BroaderTerm>
<BroaderTerm>Recombinant Viral Vaccine</BroaderTerm>
<BroaderTerm>Biological Response Modifier</BroaderTerm>
<BroaderTerm>Drug, Food, Chemical or Biomedical Material</BroaderTerm>
<BroaderTerm>Vaccine</BroaderTerm>
<Synonym>Recombinant Vaccinia-PSA</Synonym>
<Synonym>Recombinant Vaccinia-Prostate Specific Antigen</Synonym>
<Synonym>rV-PSA</Synonym>
<Description>A recombinant vaccinia virus encoding prostate-specific antigen (PSA).  Vaccination with recombinant vaccinia-PSA may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against tumor cells positive for PSA, which may decrease tumor growth. (NCI04)</Description>
<Source>NCI Thesaurus</Source>
</Record>
